| Category: |
Antibody |
| Concentration: |
pH 7, with 0, 09% sodium azide, 4, In 1X PBS |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
APOA2 (Apolipoprotein A-II) |
| Host animal: |
Rabbit (Oryctolagus cuniculus) |
| Clonality: |
Polyclonal (rabbit origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA, WB |
| Recommended dilutions: |
Western blot: 1:1000 |
| Notes: |
Titration of the APOA2 antibody may be required due to differences in protocols and secondary/substrate sensitivity |
| Intented use: |
This APOA2 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot #: |
P02652 |
| Purity: |
Antigen affinity |
| Description: |
and affect the HDL metabolism, May stabilize HDL (high density lipoprotein) structure by its association with lipids |
| Immunogen: |
A portion of amino acids 23-56 from the human protein was used as the immunogen for this APOA2 antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot the APOA2 antibody and store frozen at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
APOA2 (Apolipoprotein A-II) |
| Short name: |
APOA2 Antibody (Apolipoprotein A-II) |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
apolipoprotein A-II (Antibody to) (Apolipoprotein A-II) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APOA2 and IDBG-104234 and ENSG00000158874 and 336, APOA2 and IDBG-630130 and ENSBTAG00000009212 and 505394, Apo-AII and ApoA-II and apoAII, Apoa2 and IDBG-204212 and ENSMUSG00000005681 and 11807, Extracellular, high-density lipoprotein particle receptor binding, this GO :0001523 and retinoid metabolic process and biological process this GO :0002526 and acute inflammatory response and biological process this GO :0002740 and negative regulation of cytokine secretion involved in immune response and biological process this GO :0005319 and lipid transporter activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0005788 and endoplasmic reticulum lumen and cellular component this GO :0005829 and cytosol and cellular component this GO :0006457 and protein folding and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006656 and phosphatidylcholine biosynthetic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0005319 : lipid transporter activity, this GO :0005319 : lipid transporter activity and also this GO :0005515 : protein binding and also this GO :0005543 : phospholipid binding and also this GO :0008035 : high-density lipoprotein particle binding and also this GO :0008289 : lipid binding and also this GO :0015485 : cholesterol binding and also this GO :0017127 : cholesterol transporter activity and also this GO :0031210 : phosphatidylcholine binding and also this GO :0034190 : apolipoprotein receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity and also this GO :0055102 : lipase inhibitor activity and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity and also this GO :0070653 : high-density lipoprotein particle receptor binding, this GO :0005515 : protein binding, this GO :0005543 : phospholipid binding, this GO :0008035 : high-density lipoprotein particle binding, this GO :0008289 : lipid binding, this GO :0015485 : cholesterol binding, this GO :0017127 : cholesterol transporter activity, this GO :0031210 : phosphatidylcholine binding, this GO :0034190 : apolipoprotein receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, this GO :0055102 : lipase inhibitor activity, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0070653 : high-density lipoprotein particle receptor binding, visible light and biological process this GO :0008035 and high-density lipoprotein particle binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0009395 and phospholipid catabolic process and biological process this GO :0009749 and response to glucose and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010903 and negative regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0016032 and viral process and biological process this GO :0017127 and cholesterol transporter activity and molecular function this GO :0018158 and protein oxidation and biological process this GO :0018206 and peptidyl-methionine modification and biological process this GO :0030300 and regulation of intestinal cholesterol absorption and biological process this GO :0030301 and cholesterol transport and biological process this GO :0031100 and organ regeneration and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0031647 and regulation of protein stability and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034374 and low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034380 and high-density lipoprotein particle assembly and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042493 and response to drug and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043627 and response to estrogen and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045416 and positive regulation of interleukin-8 biosynthetic process and biological process this GO :0046340 and diacylglycerol catabolic process and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0050996 and positive regulation of lipid catabolic process and biological process this GO :0051384 and response to glucocorticoid and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060192 and negative regulation of lipase activity and biological process this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0060621 and negative regulation of cholesterol import and biological process this GO :0060695 and negative regulation of cholesterol transporter activity and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070653 and high-density lipoprotein particle receptor binding and molecular function this GO :0072562 and blood microparticle and cellular component, apolipoprotein A-II |
| Identity: |
601 |
| Gene: |
APOA2 |
More about : APOA2 |
| Long gene name: |
apolipoprotein A2 |
| Synonyms gene name: |
apolipoprotein A-II |
| Locus: |
1q23, 3 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
336 |
| Pubmed identfication: |
2415515 |
| RefSeq identity: |
NM_001643 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000034346 |